Represented Appellee Genentech before the Federal Circuit in a successful defense of a favorable jury verdict that Chiron's asserted patent is invalid and Genentech's breast cancer drug Herceptin® does not infringe. The Federal Circuit issued a precedential decision upholding the jury verdict.